Status:
RECRUITING
Resting Full-cycle Flow Ratio (RFR) Versus Angiography to Guide Revascularization Strategy in Patients Undergoing Coronary Artery By-pass Grafting (CABG)
Lead Sponsor:
Diagram B.V.
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Different trials have shown that fractional flow reserve (FFR) could successfully guide revascularization in patients undergoing percutaneous coronary intervention (PCI). It is conceivable that a sim...
Eligibility Criteria
Inclusion
- All patients between 18 or older undergoing CABG
- Patients willing and capable to provide written informed consent
Exclusion
- Previous CABG
- Concomitant severe valvular disease intervention
- Remaining (expected) coronary stenosis of \> 50% diameter stenosis distally to graft anastomosis
- Left ventricular ejection fraction \<30%
- Known transmural myocardial infarction
- Documented microvascular disease
- RFR/FFR measurement judged impossible
- Life expectancy \<2 years
- Participation in other investigational clinical trials
Key Trial Info
Start Date :
February 3 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2027
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04375306
Start Date
February 3 2020
End Date
June 30 2027
Last Update
February 1 2024
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Imelda ziekenhuis
Bonheiden, Belgium
2
AZ Sint-Jan Brugge
Bruges, Belgium
3
Medical University of Silesia
Katowice, Poland
4
SUSCCH
Banská Bystrica, Slovakia